2012

Secukinumab in mode-severe CD

Infliximab switch to adalimumab in CD

A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn’s disease

Adalimumab in patients with CD from Japan

Adalimumab, azathioprine or 5ASA in postoperative recurrence in CD

Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis

Ustekinumab in CD

Budesonide MMX in UC

Cyclosporin vs infliximab in ASUC

Abatacept for Crohn’s Disease and Ulcerative Colitis